SKI Market

Indian Indices

Nifty

24,414.40 34.80
(0.14%)

Sensex

80,777.71 30.93
( 0.04%)

Bank Nifty

54,610.90 339.50
( 0.63%)

Nifty IT

35,920.30 51.10
( 0.14%)

Global Indices

Nasdaq

41,122.95 272.95
(0.67%)

Dow Jones

5,652.59 24.68
(0.44%)

Hang Seng

36,847.73 17.04
(0.05%)

Nikkei 225

8,559.33 -38.09
(-0.44%)

Forex

USD-INR

84.41 0.15
(0.18%)

EUR-INR

95.67 0.23
(0.24%)

GBP-INR

112.57 0.57
(0.51%)

JPY-INR

0.59 0.00
(0.80%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

290.2218799

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

34.02

31192.42

EPS(TTM)

Face Value()

Div & Yield %

73.4

1.13

Back

Naperol Investments Ltd - Audited Financial Results For Quarter And Year Ended March 31 2025

May 06,2025

The Board in its meeting held on May 06 2025 have considered and approved Audited Financial Results for quarter and year ended March 31 2025.

24,414.40 34.80 (0.14%)

80,777.71 30.93 ( 0.04%)

54,610.90 339.50 ( 0.63%)

35,920.30 51.10 ( 0.14%)

41,122.95 272.95 (0.67%)

5,652.59 24.68 (0.44%)

36,847.73 17.04 (0.05%)

8,559.33 -38.09 (-0.44%)

84.41 0.15 (0.18%)

95.67 0.23 (0.24%)

112.57 0.57 (0.51%)

0.59 0.00 (0.80%)